Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-300914 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
18,750
Total Value
$0.00
P&L
+inf% (+$114,562.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer, EVP | Stock Option (right to buy) | Derivative | Jul 8, 2026 | Grant/Award | 18,750 | $0.00 | $0.00 | 18,750 | Direct | โ | View Details |